Elizabeth Anne Whalley Buono

Liz brings a deep understanding of current healthcare market complexities and over 25 years of life science experience. She has extensive experience in legal, regulatory, operational and executive roles in drug, device, tobacco, clinical research and healthcare packaging companies. After careers in clinical nursing and big pharma, Liz obtained a JD in Health Law and Economics and began her legal career practicing Food & Drug, Fraud & Abuse, Insurance and Privacy law.

Transitioning in-house to Altria Client Services, Liz managed the legal, regulatory and ethics considerations associated with tobacco harm reduction clinical research and new product development. At WestRock, Liz focused her business and legal acumen into a dual law and executive role with jurisdiction over global healthcare regulatory and legal support for the company’s healthcare innovation work.

Liz has been integral in creating an innovative manufacturer to retail supply chain model for Walmart, permitting introduction of the first US $5.00 generic drug program and the first retail-branded adherence program. Additionally, she worked with CVS to pilot hardware and software designed to dispense personalized co-mingled co-packaged daily medication.

“Nothing is more critical to our future than activities conducted within the life sciences industry. Brilliant minds engaged in the discovery, design, development and commercialization of new medicines and treatments for diseases are bringing us closer every day to winning our longstanding war with illness and suffering. Today, the life sciences industry is experiencing a period of unprecedented growth and advancement in technology. This evolution, however, is accompanied by significant compliance challenges and ever-increasing regulatory scrutiny. I consider it a privilege to help our clients overcome these challenges and achieve their critically-important business goals by bringing a unique combination of value-based legal expertise, ethical focus, scientific knowledge and business acumen to each project.”

Most recently, Liz has been sharing her perspectives in public health policy as part of the FDA’s expert working group on activities aimed at addressing abuse, misuse, or inappropriate access of prescription opioid drug products and as part of The Bill and Melinda Gates Foundation funded work on HIV and TB clinical trials in underserved regions.



Boston College School of Nursing, BSN/RN
St. John’s University, MBA
George Mason University School of Law, J.D. Licensure


District of Columbia

Full Bio